Search
for
Sort by
Research 361–390 of 1000+
- Telogen effluvium
- Fulvestrant, a new treatment option for advanced breast cancer: tolerability versus existing agents
- Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study
- Interventions for nail psoriasis
- The Therapeutic Effect and the Changed Serum Zinc Level after Zinc Supplementation in Alopecia Areata Patients Who Had a Low Serum Zinc Level
- Efficacy of myo-inositol in the treatment of cutaneous disorders in young women with polycystic ovary syndrome
- Lithium therapy associated with hidradenitis suppurativa: Case report and a review of the dermatologic side effects of lithium
- PHYSIOLOGIC SKIN CHANGES ASSOCIATED WITH PREGNANCY
- DRUG‐ASSOCIATED ALOPECIA
- Frontal Fibrosing Alopecia: An Update on Pathogenesis, Diagnosis, and Treatment
- Graft-versus-host disease
- Adverse Reactions to Oral Retinoids An Update
- Increasing tinea capitis prevalence in Stockholm reflects immigration
- Compliance With Contraceptives and Other Treatments
- Oral Retinoids in Dermatology
- Efficacy of tofacitinib in treatment of alopecia universalis in two patients
- Oral Manifestations of Hematologic and Nutritional Diseases
- Nutrition Strategy and Life Style in Polycystic Ovary Syndrome—Narrative Review
- Delayed-Onset Hemolytic Anemia in Patients with Travel-Associated Severe Malaria Treated with Artesunate, France, 2011–2013
- TREATMENT OF ALOPECIA AREATA
- TOXIC EPIDERMAL NECROLYSIS
- Hormonal treatment of acne vulgaris: an update
- <i>Acorus calamus</i>: a bio-reserve of medicinal values
- Alopecia in patients treated with molecularly targeted anticancer therapies
- Mitoxantrone
- Alternative treatment of polycystic ovary syndrome: pre-clinical and clinical basis for using plant-based drugs
- Systemic treatments for alopecia areata: A systematic review
- Psychodermatology
- A Practical Approach to the Diagnosis and Management of Hair Loss in Children and Adolescents
- Update on the dermatologic use of systemic glucocorticosteroids